Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Over the last 12 months, insiders at Quest Diagnostics Incorporated have bought $0 and sold $2.31M worth of Quest Diagnostics Incorporated stock.
On average, over the past 5 years, insiders at Quest Diagnostics Incorporated have bought $0 and sold $54.72M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 8,000 shares for transaction amount of $444,046 was made by GUINAN MARK (Senior Vice President & CFO) on 2014‑05‑05.
2024-04-29 | Sale | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 1,760 0.0016% | $140.00 | $246,400 | -0.27% | |
2024-02-29 | Sale | Doherty Catherine T. | EVP, Regional Businesses | 1,187 0.0011% | $125.88 | $149,420 | +9.18% | |
2024-02-29 | Sale | PREVOZNIK MICHAEL E | SVP & General Counsel | 5,611 0.0051% | $125.88 | $706,313 | +9.18% | |
2024-02-28 | Sale | Doherty Catherine T. | EVP, Regional Businesses | 5,557 0.0051% | $126.57 | $703,349 | +8.34% | |
2024-02-23 | Sale | Gregg Vicky B | director | 2,500 0.0022% | $126.64 | $316,597 | +6.63% | |
2024-02-22 | Sale | Doherty Catherine T. | EVP, Regional Businesses | 821 0.0007% | $126.14 | $103,561 | +8.04% | |
2024-02-22 | Sale | PREVOZNIK MICHAEL E | SVP & General Counsel | 661 0.0006% | $126.14 | $83,379 | +8.04% | |
2023-03-07 | Sale | Doherty Catherine T. | SVP, Regional Businesses | 5,307 0.0048% | $140.55 | $745,899 | -1.82% | |
2023-03-07 | Sale | PREVOZNIK MICHAEL E | SVP & General Counsel | 4,754 0.0043% | $140.55 | $668,175 | -1.82% | |
2023-03-03 | Sale | Doherty Catherine T. | SVP, Regional Businesses | 717 0.0006% | $140.63 | $100,832 | -3.84% | |
2023-03-02 | Sale | PREVOZNIK MICHAEL E | SVP & General Counsel | 593 0.0005% | $138.54 | $82,154 | -3.09% | |
2023-02-24 | Sale | Doherty Catherine T. | SVP, Regional Businesses | 1,690 0.0015% | $141.42 | $239,000 | -2.95% | |
2023-02-24 | Sale | PREVOZNIK MICHAEL E | SVP & General Counsel | 1,415 0.0013% | $141.42 | $200,109 | -2.95% | |
2022-12-01 | Sale | RING TIMOTHY M | director | 2,025 0.0017% | $152.50 | $308,813 | -9.67% | |
2022-11-28 | Sale | Doherty Catherine T. | SVP, Regional Businesses | 40,765 0.0352% | $149.18 | $6.08M | -7.47% | |
2022-11-01 | Sale | RING TIMOTHY M | director | 2,000 0.0017% | $144.06 | $288,120 | -1.87% | |
2022-10-26 | Sale | DEPPE MICHAEL J | VP, Corp. Controller & CAO | 15,497 0.0135% | $145.00 | $2.25M | -2.12% | |
2022-10-03 | Sale | RING TIMOTHY M | director | 2,000 0.0017% | $123.39 | $246,780 | ||
2022-09-01 | Sale | RING TIMOTHY M | 2,000 0.0017% | $125.02 | $250,040 | +12.13% | ||
2022-08-01 | Sale | RING TIMOTHY M | 2,000 0.0017% | $136.04 | $272,080 | +3.47% |
Doherty Catherine T. | SVP, Regional Businesses | 68412 0.0603% | $138.60 | 0 | 35 | |
PREVOZNIK MICHAEL E | SVP & General Counsel | 38478 0.0343% | $138.60 | 0 | 65 | |
Gregg Vicky B | director | 16329 0.0147% | $138.60 | 0 | 1 | |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 13435 0.0121% | $138.60 | 0 | 1 | |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 334833 0.2978% | $138.60 | 2 | 16 | +0.94% |
FREEMAN KENNETH W/NJ | Chairman of the Board | 248457 0.221% | $138.60 | 0 | 46 | |
MOHAPATRA SURYA N | Chairman, President & CEO | 200126 0.178% | $138.60 | 0 | 26 | |
HAGEMANN ROBERT | SVP & Chief Financial Officer | 154603 0.1375% | $138.60 | 0 | 34 | |
GUINAN MARK | Executive Vice President & CFO | 73579 0.0654% | $138.60 | 1 | 5 | +14.91% |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | 73373 0.0653% | $138.60 | 0 | 20 | |
MARRONE GERALD C | SVP, Administration | 55397 0.0493% | $138.60 | 0 | 2 | |
Simmons Wayne R. | Vice President, Operations | 47150 0.0419% | $138.60 | 0 | 4 | |
Cunningham Everett | SVP, Commercial | 38311 0.0341% | $138.60 | 0 | 8 | |
Davis J. E. | EVP, General Diagnostics | 38086 0.0339% | $138.60 | 0 | 12 | |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 32013 0.0285% | $138.60 | 0 | 3 | |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | 31757 0.0282% | $138.60 | 0 | 4 | |
ZEWE DAVID M | SVP, Diagnostic Testing Ops | 31079 0.0276% | $138.60 | 0 | 6 | |
STANZIONE DANIEL | director | 28349 0.0252% | $138.60 | 1 | 9 | +6.37% |
BUEHLER WILLIAM F | director | 26225 0.0233% | $138.60 | 0 | 6 | |
RING TIMOTHY M | director | 24149 0.0215% | $138.60 | 0 | 7 | |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 22390 0.0199% | $138.60 | 0 | 1 | |
BRITELL JENNE K | director | 19903 0.0177% | $138.60 | 0 | 9 | |
WILENSKY GAIL R | director | 17845 0.0159% | $138.60 | 0 | 14 | |
ZIEGLER JOHN B | director | 16557 0.0147% | $138.60 | 0 | 21 | |
PFEIFFER GARY M | director | 13698 0.0122% | $138.60 | 0 | 7 | |
Peters Robert E | VP, Sales & Marketing | 12974 0.0115% | $138.60 | 0 | 1 | |
BALDWIN JOHN C MD | director | 12949 0.0115% | $138.60 | 0 | 9 | |
BONGIORNO THOMAS F | VP and Corporate Controller | 12477 0.0111% | $138.60 | 1 | 24 | +3.61% |
HAGGERTY ROSANNE | director | 6000 0.0053% | $138.60 | 0 | 1 | |
LEIDEN JEFFREY M | director | 6000 0.0053% | $138.60 | 0 | 4 | |
MAIN TIMOTHY L | director | 5658 0.005% | $138.60 | 1 | 0 | +20.26% |
CIRILLO MARY A | director | 4132 0.0037% | $138.60 | 0 | 3 | |
Klug Robert A | VP, Corporate Controller | 3903 0.0035% | $138.60 | 0 | 1 | |
GRANT WILLIAM R | director | 3334 0.003% | $138.60 | 0 | 2 | |
BRODY KENNETH D | director | 0 0% | $138.60 | 0 | 9 | |
GLAXOSMITHKLINE PLC | director, 10 percent owner | 0 0% | $138.60 | 0 | 6 | |
FLAHERTY JAMES F III | director | 0 0% | $138.60 | 3 | 1 | +20.4% |
The Vanguard Group | $1.85B | 12.53 | 13.92M | +2.55% | +$46.02M | 0.04 | |
BlackRock | $1.42B | 9.63 | 10.7M | +1.16% | +$16.27M | 0.03 | |
State Street | $692.06M | 4.68 | 5.2M | -2.46% | -$17.43M | 0.03 | |
Victory Capital Management Inc | $522.1M | 3.53 | 3.92M | +12.82% | +$59.33M | 0.53 | |
American Century Investments | $515.63M | 3.49 | 3.87M | +7.01% | +$33.76M | 0.32 | |
Wellington Management Company | $347.79M | 2.35 | 2.61M | -0.74% | -$2.6M | 0.06 | |
Geode Capital Management | $336.31M | 2.28 | 2.53M | +0.04% | +$124,909.02 | 0.03 | |
Davis Selected Advisers | $316.96M | 2.14 | 2.38M | -10.7% | -$37.99M | 1.81 | |
Grantham Mayo Van Otterloo & Co LLC | $271.98M | 1.84 | 2.04M | +19.83% | +$45.01M | 0.99 | |
Dimensional Fund Advisors | $263.57M | 1.78 | 1.98M | +0.35% | +$931,903.41 | 0.07 | |
Invesco | $260.98M | 1.77 | 1.96M | +14.06% | +$32.17M | 0.06 | |
Morgan Stanley | $246.44M | 1.67 | 1.85M | -0.79% | -$1.96M | 0.02 | |
Goldman Sachs | $246.24M | 1.67 | 1.85M | +275.49% | +$180.66M | 0.05 | |
JPMorgan Chase | $242.73M | 1.64 | 1.82M | -2.37% | -$5.89M | 0.02 | |
Wells Fargo | $210.01M | 1.42 | 1.58M | +2.25% | +$4.62M | 0.06 | |
Fiduciary Management, Inc. (FMI) | $199.48M | 1.35 | 1.5M | New | +$199.48M | 1.78 | |
Fidelity Investments | $174.23M | 1.18 | 1.31M | -1.79% | -$3.18M | 0.01 | |
Northern Trust | $138.99M | 0.94 | 1.04M | -5.88% | -$8.68M | 0.02 | |
Bank of America | $136.94M | 0.93 | 1.03M | +0.53% | +$714,800.96 | 0.01 | |
Legal & General | $129.54M | 0.88 | 973,164 | -4.7% | -$6.38M | 0.03 | |
Ubs Asset Management Americas Inc | $110.15M | 0.75 | 827,541 | -17.99% | -$24.17M | 0.04 | |
BNY Mellon | $107.19M | 0.73 | 805,307 | -4.05% | -$4.52M | 0.02 | |
Ameriprise Financial | $105.65M | 0.71 | 793,622 | -22.2% | -$30.14M | 0.03 | |
DekaBank | $99.99M | 0.69 | 765,938 | -1.65% | -$1.67M | 0.19 | |
First Trust | $99.68M | 0.67 | 748,837 | +1.24% | +$1.22M | 0.1 | |
HSBC | $92.13M | 0.62 | 692,062 | +0.92% | +$841,228.61 | 0.07 | |
CalPERS | $91.65M | 0.62 | 688,551 | -2.95% | -$2.78M | 0.06 | |
Nuance Investments | $90.73M | 0.61 | 681,636 | +13.14% | +$10.54M | 2.38 | |
Charles Schwab | $90.56M | 0.61 | 680,325 | +2.47% | +$2.18M | 0.02 | |
Bessemer Group Inc | $87.92M | 0.6 | 660,483 | -26.5% | -$31.7M | 0.16 | |
Nordea Investment Management Ab | $78.96M | 0.54 | 596,482 | -2.78% | -$2.26M | 0.09 | |
Marshall Wace | $78.03M | 0.53 | 586,199 | +248.23% | +$55.62M | 0.1 | |
Amundi | $71.08M | 0.51 | 564,525 | +33.82% | +$17.96M | 0.03 | |
Causeway Capital Management | $66.74M | 0.45 | 501,117 | +1.71% | +$1.12M | 1.75 | |
Barclays | $62.75M | 0.42 | 471,395 | +23.68% | +$12.01M | 0.03 | |
AllianceBernstein | $61.08M | 0.41 | 458,874 | -27.82% | -$23.55M | 0.02 | |
Deutsche Bank | $59.81M | 0.4 | 449,315 | -0.19% | -$111,945.51 | 0.03 | |
Standard Life | $57.03M | 0.39 | 428,453 | +6.75% | +$3.61M | 0.11 | |
Crawford Investment Counsel | $55.56M | 0.38 | 417,362 | New | +$55.56M | 1.04 | |
Macquarie Group | $55.23M | 0.37 | 414,889 | +2.24% | +$1.21M | 0.05 | |
Nuveen | $47.9M | 0.33 | 360,811 | +5.13% | +$2.34M | 0.01 | |
Swiss National Bank | $44.82M | 0.3 | 336,700 | -4.07% | -$1.9M | 0.03 | |
Robeco Institutional Asset Management B.V. | $43.27M | 0.29 | 325,076 | -29.19% | -$17.84M | 0.09 | |
APG Asset Management | $39.46M | 0.29 | 320,145 | +12.3% | +$4.32M | 0.07 | |
UBS | $42.51M | 0.29 | 319,378 | -9.21% | -$4.31M | 0.01 | |
LSV Asset Management | $41.97M | 0.28 | 315,320 | -15.86% | -$7.91M | 0.09 | |
Sumitomo Mitsui Trust Holdings | $39.88M | 0.27 | 299,596 | -2.23% | -$909,407.53 | 0.03 | |
RhumbLine Advisers | $39M | 0.26 | 293,013 | +3.52% | +$1.33M | 0.04 | |
SEI Investments Company | $37.15M | 0.25 | 279,105 | +13.45% | +$4.4M | 0.06 | |
Dz Bank Ag Deutsche Zentral Genossenschafts Bank Frankfurt Am Main | $36.63M | 0.25 | 275,205 | +6.03% | +$2.08M | 0.04 |